UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INSI
4701
DELISTED
Insight Select Income Fund
INSI
| $272K | ﹤0.01% |
13,496
+1,562
| +13% | +$29.8K |
|
4702
CTS Corp
CTS
$1.89B
| $271K | ﹤0.01% |
9,809
+6,254
| +176% | +$180K |
|
4703
Koppers
KOP
$1.01B
| $271K | ﹤0.01% |
9,234
+6,779
| +276% | +$189K |
|
4704
Phibro Animal Health
PAHC
$1.44B
| $271K | ﹤0.01% |
8,508
-45,150
| -84% | -$1.42M |
|
4705
Rigel Pharmaceuticals
RIGL
$733M
| $270K | ﹤0.01% |
10,349
+4,380
| +73% | +$98.9K |
|
4706
TriNet
TNET
$3.06B
| $270K | ﹤0.01% |
3,985
+1,278
| +47% | +$81.3K |
|
|
WPS
4707
DELISTED
iShares International Developed Property ETF
WPS
| $270K | ﹤0.01% |
7,108
-102,174
| -93% | -$3.89M |
|
4708
Globalstar
GSAT
$10.7B
| $269K | ﹤0.01% |
37,399
-7,544
| -17% | -$59.1K |
|
4709
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$322M
| $269K | ﹤0.01% |
10,278
+3,078
| +43% | +$79.3K |
|
|
SEVN
4710
Seven Hills Realty Trust
SEVN
$175M
| $269K | ﹤0.01% |
14,694
-4,183
| -22% | -$77.9K |
|
4711
Forrester Research
FORR
$233M
| $268K | ﹤0.01% |
5,699
+4,591
| +414% | +$221K |
|
|
NGD
4712
DELISTED
New Gold Inc
NGD
| $268K | ﹤0.01% |
278,317
-58,887
| -17% | -$46.8K |
|
|
NHS
4713
Neuberger High Yield Strategies Fund Inc
NHS
$254M
| $268K | ﹤0.01% |
22,910
-11,023
| -32% | -$129K |
|
4714
CytomX Therapeutics
CTMX
$734M
| $267K | ﹤0.01% |
23,828
+11,790
| +98% | +$124K |
|
4715
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
| $267K | ﹤0.01% |
20,584
+6,473
| +46% | +$82.6K |
|
|
UBA
4716
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $267K | ﹤0.01% |
12,719
+11,239
| +759% | +$244K |
|
4717
Compugen
CGEN
$218M
| $266K | ﹤0.01% |
69,223
-22,361
| -24% | -$79.1K |
|
|
CHCT
4718
Community Healthcare Trust
CHCT
$446M
| $266K | ﹤0.01% |
6,741
+2,920
| +76% | +$109K |
|
|
CSLT
4719
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $266K | ﹤0.01% |
82,248
+15,651
| +24% | +$53.9K |
|
4720
Clean Energy Fuels
CLNE
$410M
| $265K | ﹤0.01% |
98,948
+94,881
| +2,333% | +$276K |
|
4721
PUT
Novartis
NVS
$293B
| $265K | ﹤0.01% |
2,900
+1,449
| +100% | +$123K |
|
|
HSACU
4722
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
| $265K | ﹤0.01% |
+25,000
| New | +$260K |
|
4723
Empire State Realty Series ES
ESBA
$1.36B
| $264K | ﹤0.01% |
17,805
-5,025
| -22% | -$77.5K |
|
4724
PRA Group
PRAA
$692M
| $264K | ﹤0.01% |
9,388
+8,250
| +725% | +$233K |
|
4725
iShares Asia/Pacific Dividend ETF
DVYA
$71.5M
| $263K | ﹤0.01% |
5,977
+1,500
| +34% | +$65.2K |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 809 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.